2018 11th Annual RNS Conference
Course

2018 Annual RNS Conference Enduring Series

The 2018 Conference Enduring Course consists of a series of videos from passionate experts that presented at the 2018 11th Annual RNS Conference in Fort Worth, Texas.

0 out of 7 steps completed0%
0 Lessons

Summary

The 2018 Conference Enduring Course consists of a series of videos from passionate experts that presented at the 2018 11th Annual RNS Conference in Fort Worth, Texas. The theme for this conference was “Blazing the Trail in Rheumatology,” where together, attendees learned the most up-to-date discoveries of autoimmune diseases, the latest in treatment guidelines, and effective clinical skills to increase their practice’s efficiency. Following your participation with the Enduring Course, you will have sharpened your skills and knowledge in order to provide the necessary support and treatments for your patients. To receive CNE credit, participants must complete the course, evaluation, and post-test. A certificate of completion will be automatically generated following the completion of the course.

Target Audience

This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

Learning Objectives

  • Identify current trends and practices impacting, age-appropriate care and treatment of the rheumatology patient.
  • Compare and contrast evidence-based and evidence-informed integrated practices.
  • Implement strategies designed to enhance resource utilization and mindful use of technology and research into rheumatology practice.

Accreditation Statement

Rheumatology Nurses Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Rheumatology Nurses Society designates this educational activity for 5 total contact hours and 3 CNE pharmacotherapeutic contact hours.

Faculty Disclosures

According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Hermine Brunner, MD
Consultant: GSK, Janssen

Paul H. Caldron, DO, PhD, FACP, FACR, MBA
Other/Clinical Trials: Abbvie, Amgen, AstraZeneca, MedImmune, BMS, Celgene, Gilead, HGS/GSK, Janssen, Lilly, Mallinckrodt, Merck, Pfizer, Roche – Genentech, Sanofi, Sun Pharma, Takeda, UCB

Carole Dodge, OTRL, CHT
Nothing to disclose

Jessica Farrell, PharmD
Nothing to disclose

Kristen Lee, MD
Nothing to disclose

Monica Richey, MSN, ANP-BC/GNP
Nothing to disclose

Copyright Statement

© 2019. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).